Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06462820 · ClinicalTrials.gov registry record · Phase 2

SAINT for MDD in an Inpatient Setting Follow-on

A Phase 2 study, sponsored by Magnus Medical.

Terminated
Registry status
Phase 2
Development phase
2
Enrollment target

NCT06462820 is a Phase 2 study that was terminated before completion, run by Magnus Medical. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06462820, a Phase 2 study, was terminated before completion, sponsored by Magnus Medical.

TERMINATED
Registry status
Phase 2
Development phase
2 participants
Enrollment target

Study Summary

Randomized, multi-site, sham-controlled, double-blinded study

Interventions

  • DEVICE Sham SAINT Stimulation
  • DEVICE Active SAINT Stimulation

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2024-06-30
Est. Completion 2025-03-06
Phase Phase 2

Sponsor

Magnus Medical

4 total trials

What the Registry Record Tells You About NCT06462820

The ClinicalTrials.gov registry entry for NCT06462820 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Magnus Medical, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham SAINT Stimulation is the first listed.

NCT06462820 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06462820 about?

NCT06462820 is a clinical study titled "SAINT for MDD in an Inpatient Setting Follow-on". Randomized, multi-site, sham-controlled, double-blinded study

What is the current status of trial NCT06462820?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2024-06-30. Estimated completion is 2025-03-06.

What interventions are being tested in trial NCT06462820?

The interventions under investigation include: Sham SAINT Stimulation (DEVICE), Active SAINT Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06462820?

This trial is sponsored by Magnus Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.